109 related articles for article (PubMed ID: 26049107)
21. The SERM/SERD bazedoxifene disrupts ESR1 helix 12 to overcome acquired hormone resistance in breast cancer cells.
Fanning SW; Jeselsohn R; Dharmarajan V; Mayne CG; Karimi M; Buchwalter G; Houtman R; Toy W; Fowler CE; Han R; Lainé M; Carlson KE; Martin TA; Nowak J; Nwachukwu JC; Hosfield DJ; Chandarlapaty S; Tajkhorshid E; Nettles KW; Griffin PR; Shen Y; Katzenellenbogen JA; Brown M; Greene GL
Elife; 2018 Nov; 7():. PubMed ID: 30489256
[TBL] [Abstract][Full Text] [Related]
22. Phosphorylation of estrogen receptor alpha, serine residue 305 enhances activity.
Tharakan R; Lepont P; Singleton D; Kumar R; Khan S
Mol Cell Endocrinol; 2008 Nov; 295(1-2):70-8. PubMed ID: 18755239
[TBL] [Abstract][Full Text] [Related]
23. Estrogen receptor-α directly regulates sensitivity to paclitaxel in neoadjuvant chemotherapy for breast cancer.
Tokuda E; Seino Y; Arakawa A; Saito M; Kasumi F; Hayashi S; Yamaguchi Y
Breast Cancer Res Treat; 2012 Jun; 133(2):427-36. PubMed ID: 21909982
[TBL] [Abstract][Full Text] [Related]
24. The breast cell growth inhibitor, estrogen down regulated gene 1, modulates a novel functional interaction between estrogen receptor alpha and transcriptional elongation factor cyclin T1.
Wittmann BM; Fujinaga K; Deng H; Ogba N; Montano MM
Oncogene; 2005 Aug; 24(36):5576-88. PubMed ID: 15940264
[TBL] [Abstract][Full Text] [Related]
25. Altered target gene regulation controlled by estrogen receptor-alpha concentration.
Fowler AM; Solodin NM; Valley CC; Alarid ET
Mol Endocrinol; 2006 Feb; 20(2):291-301. PubMed ID: 16179380
[TBL] [Abstract][Full Text] [Related]
26. Proteomic identification of Profilin1 as a corepressor of estrogen receptor alpha in MCF7 breast cancer cells.
Kanaujiya JK; Lochab S; Kapoor I; Pal P; Datta D; Bhatt ML; Sanyal S; Behre G; Trivedi AK
Proteomics; 2013 Jul; 13(14):2100-12. PubMed ID: 23576398
[TBL] [Abstract][Full Text] [Related]
27. Measuring IGF-1, ER-α and EGFR expression can predict tamoxifen-resistance in ER-positive breast cancer.
Chong K; Subramanian A; Sharma A; Mokbel K
Anticancer Res; 2011 Jan; 31(1):23-32. PubMed ID: 21273576
[TBL] [Abstract][Full Text] [Related]
28. Activation of an estrogen/estrogen receptor signaling by BIG3 through its inhibitory effect on nuclear transport of PHB2/REA in breast cancer.
Kim JW; Akiyama M; Park JH; Lin ML; Shimo A; Ueki T; Daigo Y; Tsunoda T; Nishidate T; Nakamura Y; Katagiri T
Cancer Sci; 2009 Aug; 100(8):1468-78. PubMed ID: 19496786
[TBL] [Abstract][Full Text] [Related]
29. Proteomic profiling identifies key coactivators utilized by mutant ERα proteins as potential new therapeutic targets.
Gates LA; Gu G; Chen Y; Rohira AD; Lei JT; Hamilton RA; Yu Y; Lonard DM; Wang J; Wang SP; Edwards DG; Lavere PF; Shao J; Yi P; Jain A; Jung SY; Malovannaya A; Li S; Shao J; Roeder RG; Ellis MJ; Qin J; Fuqua SAW; O'Malley BW; Foulds CE
Oncogene; 2018 Aug; 37(33):4581-4598. PubMed ID: 29748621
[TBL] [Abstract][Full Text] [Related]
30. Coactivator proteins as determinants of estrogen receptor structure and function: spectroscopic evidence for a novel coactivator-stabilized receptor conformation.
Tamrazi A; Carlson KE; Rodriguez AL; Katzenellenbogen JA
Mol Endocrinol; 2005 Jun; 19(6):1516-28. PubMed ID: 15661830
[TBL] [Abstract][Full Text] [Related]
31. Altered ligand binding properties and enhanced stability of a constitutively active estrogen receptor: evidence that an open pocket conformation is required for ligand interaction.
Carlson KE; Choi I; Gee A; Katzenellenbogen BS; Katzenellenbogen JA
Biochemistry; 1997 Dec; 36(48):14897-905. PubMed ID: 9398213
[TBL] [Abstract][Full Text] [Related]
32. Stapled BIG3 helical peptide ERAP potentiates anti-tumour activity for breast cancer therapeutics.
Yoshimaru T; Aihara K; Komatsu M; Matsushita Y; Okazaki Y; Toyokuni S; Honda J; Sasa M; Miyoshi Y; Otaka A; Katagiri T
Sci Rep; 2017 May; 7(1):1821. PubMed ID: 28500289
[TBL] [Abstract][Full Text] [Related]
33. Fulvestrant (ICI 182,780) sensitizes breast cancer cells expressing estrogen receptor alpha to vinblastine and vinorelbine.
Sui M; Jiang D; Hinsch C; Fan W
Breast Cancer Res Treat; 2010 Jun; 121(2):335-45. PubMed ID: 19626437
[TBL] [Abstract][Full Text] [Related]
34. Role of estrogen receptor alpha transcriptional coregulators in tamoxifen resistance in breast cancer.
Girault I; Bièche I; Lidereau R
Maturitas; 2006 Jul; 54(4):342-51. PubMed ID: 16822624
[TBL] [Abstract][Full Text] [Related]
35. The role of 14-3-3β in transcriptional activation of estrogen receptor α and its involvement in proliferation of breast cancer cells.
Kim Y; Kim H; Jang SW; Ko J
Biochem Biophys Res Commun; 2011 Oct; 414(1):199-204. PubMed ID: 21946067
[TBL] [Abstract][Full Text] [Related]
36. Differential activation of wild-type estrogen receptor alpha and C-terminal deletion mutants by estrogens, antiestrogens and xenoestrogens in breast cancer cells.
Wu F; Safe S
J Steroid Biochem Mol Biol; 2007 Jan; 103(1):1-9. PubMed ID: 17141713
[TBL] [Abstract][Full Text] [Related]
37. Biophysical characterization of the breast cancer-related BIG3-PHB2 interaction: Effect of non-conserved loop region of BIG3 on the structure and the interaction.
Chigira T; Nagatoishi S; Takeda H; Yoshimaru T; Katagiri T; Tsumoto K
Biochem Biophys Res Commun; 2019 Oct; 518(1):183-189. PubMed ID: 31421830
[TBL] [Abstract][Full Text] [Related]
38. Mitochondrial functions and estrogen receptor-dependent nuclear translocation of pleiotropic human prohibitin 2.
Kasashima K; Ohta E; Kagawa Y; Endo H
J Biol Chem; 2006 Nov; 281(47):36401-10. PubMed ID: 17008324
[TBL] [Abstract][Full Text] [Related]
39. Structural underpinnings of oestrogen receptor mutations in endocrine therapy resistance.
Katzenellenbogen JA; Mayne CG; Katzenellenbogen BS; Greene GL; Chandarlapaty S
Nat Rev Cancer; 2018 Jun; 18(6):377-388. PubMed ID: 29662238
[TBL] [Abstract][Full Text] [Related]
40. Application of Circular Dichroism Spectroscopy to the Analysis of the Interaction Between the Estrogen Receptor Alpha and Coactivators: The Case of Calmodulin.
Miclet E; Bourgoin-Voillard S; Byrne C; Jacquot Y
Methods Mol Biol; 2016; 1366():241-259. PubMed ID: 26585140
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
